It is an immense pleasure to share the success of our conference in conjunction with Shree Hospital, Pune. on behalf of ProRelix Research we would like you all to have an insight of our conference and share a glimpse of that event.
The Central Drugs Standard Control Organization (CDSCO) has told its port offices to stop holding up the importation of medical devices on certain technical grounds.
FDA officials shared their insights on how drug makers can be more efficient when developing treatments for rare diseases, according to comments at the National Organization for Rare Disorders’ (NORD) Summit in Washington, DC.
According to the report, published by Frost & Sullivan, the global contract research organization (CRO) market is expected to grow at a compound annual growth rate (CAGR) of 12.4% to reach $57bn in 2020, up from $31.8bn in 2015.
ProRelix Lifesciences Pvt. Ltd has signed a MOU with the Life Sciences Sector Skill Development Council on 7th Feb 2017 to develop and strengthen skills in Life Sciences Sector in Maharashtra, a major cluster of Life Sciences industry. This should boost skilling activity in Pune, India by ProRelix Lifesciences in coordination with LSSSDC.